Cortigent is a leading developer of brain interface devices based on precision neurostimulation technology The company’s new ...
Cortigent is a leading developer of brain implant devices based on precision neurostimulation technology Cortigent is the only company to have ...
An estimated five million people are unable to see the world around them because they suffer from an advanced form of age-related macular degeneration (AMD) called geographic atrophy. The condition ...
An international research team led by Prof. Dr. Sedat NizamoÄŸlu from the Department of Electrical and Electronics Engineering ...
Electronic retinal implants such as the PRIMA system bypass damaged cells to restore partial central vision, bringing ...
Scientists at USC are launching a new trial to test a tiny stem cell implant that could restore vision in people with advanced dry macular degeneration. The hair-thin patch replaces damaged retinal ...
Federal Steel Systems announced the availability of its 2026 commercial building packages, introducing updated specifications intended to address evolving energy efficiency standards and permitting ...
This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of The ...
MALVERN, PA / ACCESS Newswire / January 8, 2026 / Toetal Solution, Inc., a Runway Healthcare company, announced that it has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the ...
Anytime Septic of Adairsville has announced the publication of a new blog post that focuses on Aging Septic Systems in Adairsville, GA: When to Repair vs. Replace. The article appears on the company ...
AI is reshaping clinical practice in retinal imaging and workflow optimization, according to Priv.-Doz. Dr. med. Jan H.
The ADAPT trial involves 70 refractory glaucoma patients, focusing on a 12-month primary effectiveness endpoint to evaluate the Calibreye TGT Surgical System. The Calibreye system is the first ...